A small subset of coeliac disease (CD) patients experience persisting or recurring symptoms despite strict adherence to a gluten-free diet (GFD). When other causes of villous atrophy have been excluded, these patients are referred to as refractory celiac disease (RCD) patients. RCD can be divided in two types based on the absence (type 1) or presence (type II) of an, usually clonal, intraepithelial lymphocyte population with aberrant phenotype.
10/21/2013
Update on the Diagnosis and Management of Refractory Coeliac Disease
Recent Posts
- Addressing Health Equity and Clinical Disparities – Marilyn’s Message February 2024
- Underrepresented Populations in Celiac Disease, A New Grant, and Collaborations to Improve Health Equity in Celiac Disease
- Announcing CDF–Takeda Early Career Research Award Winner Dr. Esen Sefik
- Study Reveals Black Patients More Likely to Receive Negative Blood Tests for Biopsy-Confirmed Celiac Disease
Search the archive
Categories
- Advocacy News
- Celiac Disease in the News
- Clinical Trials
- Eat! Gluten-Free
- Featured
- Foundation Press
- iCureCeliac
- Marilyn’s Message
- Monthly eNewsletter
- Patient Profile Advocacy Series
- Research News
- Research Press
- Trending Topics
Marilyn's Message
2/29/2024
Read moreAddressing Health Equity and Clinical Disparities – Marilyn’s Message February 2024
As we continue our journey toward advancing awareness and understanding of celiac disease, it is crucial that we reflect on health equity and the persistent clinical disparities within our community—so that together we can confront these factors and dismantle barriers hindering access to care and support. Health equity represents the...